Similar articles for PMID: 30774739

Year	Number of Results
2000	1
2004	2
2005	3
2006	2
2007	4
2009	5
2010	1
2011	3
2012	8
2013	4
2014	4
2015	5
2016	11
2017	10
2018	8
2019	13
2020	8
2021	2
2022	5
2023	4
2024	0

1

Cost-Effectiveness of the Aerobika® Oscillating Positive Expiratory Pressure Device in the Management of Chronic Obstructive Pulmonary Disease Exacerbations in Canada.

Thanh NX, Jacobs P, Suggett J, McIvor A, Kaplan A. Thanh NX, et al. Can Respir J. 2019 Jan 10;2019:9176504. doi: 10.1155/2019/9176504. eCollection 2019. Can Respir J. 2019. PMID: 30774739 Free PMC article.

2

Cost-effectiveness of the Aerobika* oscillating positive expiratory pressure device in the management of COPD exacerbations.

Khoudigian-Sinani S, Kowal S, Suggett JA, Coppolo DP. Khoudigian-Sinani S, et al. Int J Chron Obstruct Pulmon Dis. 2017 Oct 19;12:3065-3073. doi: 10.2147/COPD.S143334. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 29089755 Free PMC article.

3

Impact of Oscillating Positive Expiratory Pressure Device Use on Post-Discharge Hospitalizations: A Retrospective Cohort Study Comparing Patients with COPD or Chronic Bronchitis Using the Aerobika^® and Acapella^® Devices.

Tse J, Wada K, Wang Y, Coppolo D, Kushnarev V, Suggett J. Tse J, et al. Int J Chron Obstruct Pulmon Dis. 2020 Oct 19;15:2527-2538. doi: 10.2147/COPD.S256866. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 33116469 Free PMC article.

4

A Real-World Evidence Study Assessing the Impact of Adding the Aerobika Oscillating Positive Expiratory Pressure Device to Standard of Care Upon Healthcare Resource Utilization and Costs in Post-Operative Patients.

Burudpakdee C, Near AM, Huang H, Coppolo D, Kushnarev V, Suggett J. Burudpakdee C, et al. Pulm Ther. 2018 Jun;4(1):87-101. doi: 10.1007/s41030-018-0055-9. Epub 2018 May 16. Pulm Ther. 2018. PMID: 32026246 Free PMC article.

5

Development of an enhanced health-economic model and cost-effectiveness analysis of tiotropium + olodaterol Respimat® fixed-dose combination for chronic obstructive pulmonary disease patients in Italy.

Selya-Hammer C, Gonzalez-Rojas Guix N, Baldwin M, Ternouth A, Miravitlles M, Rutten-van Mölken M, Goosens LM, Buyukkaramikli N, Acciai V. Selya-Hammer C, et al. Ther Adv Respir Dis. 2016 Oct;10(5):391-401. doi: 10.1177/1753465816657272. Epub 2016 Jul 12. Ther Adv Respir Dis. 2016. PMID: 27405723 Free PMC article.

6

Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease.

Spencer M, Briggs AH, Grossman RF, Rance L. Spencer M, et al. Pharmacoeconomics. 2005;23(6):619-37. doi: 10.2165/00019053-200523060-00008. Pharmacoeconomics. 2005. PMID: 15960557

7

Corrigendum to "Cost-Effectiveness of the Aerobika® Oscillating Positive Expiratory Pressure Device in the Management of Chronic Obstructive Pulmonary Disease Exacerbations in Canada".

Thanh NX, Jacobs P, Suggett J, McIvor A, Kaplan A. Thanh NX, et al. Can Respir J. 2019 May 19;2019:5906984. doi: 10.1155/2019/5906984. eCollection 2019. Can Respir J. 2019. PMID: 31236147 Free PMC article.

8

Cost-effectiveness of physical activity in the management of COPD patients in the UK.

Ramos M, Lamotte M, Gerlier L, Svangren P, Miquel-Cases A, Haughney J. Ramos M, et al. Int J Chron Obstruct Pulmon Dis. 2019 Jan 15;14:227-239. doi: 10.2147/COPD.S181194. eCollection 2019. Int J Chron Obstruct Pulmon Dis. 2019. PMID: 30697043 Free PMC article.

9

A Functional Respiratory Imaging Approach to the Effect of an Oscillating Positive Expiratory Pressure Device in Chronic Obstructive Pulmonary Disease.

Leemans G, Belmans D, Van Holsbeke C, Kushnarev V, Sugget J, Ides K, Vissers D, De Backer W. Leemans G, et al. Int J Chron Obstruct Pulmon Dis. 2020 Jun 4;15:1261-1268. doi: 10.2147/COPD.S242191. eCollection 2020. Int J Chron Obstruct Pulmon Dis. 2020. PMID: 32581531 Free PMC article.

10

Probabilistic Markov model to assess the cost-effectiveness of bronchodilator therapy in COPD patients in different countries.

Oostenbrink JB, Rutten-van Mölken MP, Monz BU, FitzGerald JM. Oostenbrink JB, et al. Value Health. 2005 Jan-Feb;8(1):32-46. doi: 10.1111/j.1524-4733.2005.03086.x. Value Health. 2005. PMID: 15841892 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

88 results

Results by year